© 2019 IPFA  |  Sitemap  |  Disclaimer
Design by Stunnenberg

Proceedings IPFA/BCA Symposium 2017 Atlanta, USA




Proceedings IPFA/BCA 3rd Global Symposium 
on the Future for Blood and Plasma Donations 2017
Atlanta, USA

Organiser IPFA/BCA inaugural Global Symposium on the Future for Voluntary Blood and Plasma Donations

          

With our sincere appreciation and thanks to you all for contributing and participating in this year's Symposium and in particular to our speakers for agreeing to publish their presentations. Please double click on the title of the presentation you wish to view.

In case you encounter a difficulty in opening / downloading the individual presentations below, then please send an email to info@ipfa.nl

 

DAY ONE – Monday 11 September 2017
 

Session 1:
OPENING SESSION

Chair: Mr B. Block

  • Welcome and Introduction – Dr P. Strengers, IPFA (The Netherlands)

  • Presentation by Blood Assurance – Mr C Swafford, Blood Assurance (USA) – no slides

  • Opening - Dr C. Hooper, Centers for Disease Control (USA) – presentation not available

  • Key-Note Lecture “Setting the scene” – Mr P. Robert, Marketing Research Bureau, Inc. (USA)


Session 2:
PATIENTS’ PERSPECTIVE: WHY THE NECESSITY FOR INCREASING THE PLASMA PRODUCTION? 
Chair: Mr M. Skinner

  • Value of immunoglobuline products for GBS / CIDP patients – Mr J. Crone, GBS / CIDP Foundation International (USA)

  • Living with von Willebrand disease – Ms J. Graham and Mr J. Kocsis (USA) (20 mins)

  • Clinical use of plasma products including impact of new developments in the optimal production and potential use of Plasma-derived medicinal products – Dr S. Stowell, Emory University School of Medicine (USA) – presentation not available

  • Panel discussion


Session 3:
STRATEGIC APPROACHES TO THE SECURITY OF THE SUPPLY
Chair: Dr P. Strengers


Session 4:
PRACTICAL, OPERATIONAL APPROACHES FOR CHANGING A BLOOD CENTER INTO A BLOOD/PLASMA COLLECTION CENTER
Chair: Ms J. Ficenec


DAY TWO – Tuesday 12 September 2017
 

Session 5:
MANUFACTURERS’ SESSION
Chair: Dr F. Rossi


Session 6:
TTIs AND MICROBIOLOGICAL RISKS
Chair: Dr R. Perry


Session 7:
REGULATORY CONVERGENCE
Chair: Ms R. Sylvester


Session 8:
A VIEW ON THE FUTURE
Chair: Mr R. Van Tuyle

  • Plasma Based Medicines – A Distributors’ Perspective – Ms L. Matthews BioCARE (USA) - presented by Mr D. Schodt (USA)presentation not available

  • A view of the Hospital Marketplace – Mr W. Woodward, Vizient Inc. (USA)


CLOSURE
Meeting closure - Mr R. Van Tuyle, IPFA President

 


Save the dates! 

IPFA 3rd Asia
Workshop
Kuala Lumpur, Malaysia

21 - 22 March 2018

Save the dates! 

IPFA/PEI 25th International
Workshop
Athens, Greece

16 - 17 May 2018